Early Access — free while we kick the tires
EdgarHawk

Valle William

Director

Director
1 filing analyzed · 1 company · Latest 2026-02-23

Companies

Company Buys Sells Direction
TriSalus Life Sciences, Inc. TLSI 1 0 Net buying

Activity

February 2026
high
Buy
30,487 shares
$124,997
Significance 6/10

Director Valle William buys 30.5K shares of TLSI at $4.10; stock down -33.5% from 52-week high, net income negative; cluster of 4 other insiders bought within 14 days.

Valle William, a director, purchased 30,487 shares at $4.10 on 2026-02-23, establishing an initial position of 30.5K shares. This transaction occurs within a 14-day window where 4 other insiders also bought TLSI stock, forming a cluster buy pattern. The company's recent fundamentals are mixed: annual revenue growth of +59.0% is offset by a negative net income of $-10.8M in the latest quarter and a full-year loss, while the stock has declined -33.5% from its 52-week high of $7.50 and -8.3% over the past 30 days. The simultaneous buying activity by multiple insiders suggests coordinated interest in the stock at depressed price levels, though the company's continued unprofitability and recent downward momentum are relevant context for evaluating the signal.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access